These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4163130)

  • 1. Cushing's syndrome: use of lysine vasopressin to distinguish overproduction of corticotrophin by pituitary from other causes of adrenal cortical hyperfunction.
    Webb-Peploe MM; Spathis GS; Reed PI
    Lancet; 1967 Jan; 1(7483):195-7. PubMed ID: 4163130
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of lysine-vasopressin on blood cortisol levels. Practical implications].
    Mornex R; Mallein R; Fitoussi R; Riviere JF; Pellet H; Dechavanne M
    Rev Fr Endocrinol Clin; 1971; 12(2):105-25. PubMed ID: 5138510
    [No Abstract]   [Full Text] [Related]  

  • 3. Cushing's syndrome associated with a "corticotrophin"-producing bronchial neoplasm neoplasm (results of corticotrophin assays and of pituitary-adrenal function tests).
    Landon J; James VH; Peart WS
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):321-32. PubMed ID: 4293813
    [No Abstract]   [Full Text] [Related]  

  • 4. [A test of rapid inhibition of the pituitary-adrenal axis (single dose of dexamethasone)].
    Bricaire H; Leprat J; Laudat P; Luxton JP; Milgrom E; Laurent D
    Ann Endocrinol (Paris); 1967; 28(1):65-70. PubMed ID: 6060425
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasopressin test in an adrenocorticotrophic-hormone-producing tumor.
    Hauger-Klevene JH
    Ann Intern Med; 1969 Jan; 70(1):235-6. PubMed ID: 4303301
    [No Abstract]   [Full Text] [Related]  

  • 6. Alcohol-induced pseudo-Cushing's syndrome.
    Rees LH; Besser GM; Jeffcoate WJ; Goldie DJ; Marks V
    Lancet; 1977 Apr; 1(8014):726-8. PubMed ID: 66521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of lysin-vasopressin in the differential diagnosis of cushing's syndrome.
    Croughs RJ
    Acta Endocrinol (Copenh); 1970 Dec; 65(4):595-607. PubMed ID: 5536687
    [No Abstract]   [Full Text] [Related]  

  • 9. [Frequent determination of blood cortisol in a case of Cushing's syndrome due to adrenal cortex adenoma].
    Tourniaire J; Orgiazzi J; Riviere JF; Rousset H
    Ann Endocrinol (Paris); 1971; 52(4):583-7. PubMed ID: 5139437
    [No Abstract]   [Full Text] [Related]  

  • 10. A FOUR-DAY CORTICOTROPHIN-SUPPRESSION TEST. STUDIES IN CUSHING'S SYNDROME AND IN NON CUSHING SUBJECTS WITH RELATED SYMPTOMS.
    ERNEST I
    Acta Endocrinol (Copenh); 1965 Jan; 48():147-62. PubMed ID: 14254767
    [No Abstract]   [Full Text] [Related]  

  • 11. Cushing's syndrome: diagnosis and surgical management.
    Pridgen WR; Tipton BK; Pitcock JA
    South Med J; 1973 Mar; 66(3):313-6. PubMed ID: 4691009
    [No Abstract]   [Full Text] [Related]  

  • 12. Cushing's syndrome: problems in diagnosis.
    Aron DC; Tyrrell JB; Fitzgerald PA; Findling JW; Forsham PH
    Medicine (Baltimore); 1981 Jan; 60(1):25-35. PubMed ID: 7453563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paradoxical response to dexamethasone. A contribution to the differential diagnosis of adrenal hyperfunction?].
    Serrera Contreras JL; Molina Miró J; Astorga Jiménez R
    Rev Iber Endocrinol; 1974; 21(122):127-48. PubMed ID: 4364544
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cushing's disease caused by adrenocortical nodular hyperplasia--diagnosis and surgical treatment].
    Miura M; Matsukado Y; Kodama T; Hiramatsu R
    No Shinkei Geka; 1984 May; 12(6):689-96. PubMed ID: 6087181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cushing's syndrome: diagnostic exploration].
    Tabarin A; Roger P
    Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADRENOCORTICAL HYPERFUNCTION AND POTASSIUM METABOLISM IN PATIENTS WITH "NON- ENDOCRINE" TUMORS AND CUSHING'S SYNDROME.
    PRUNTY FT; BROOKS RV; DUPRE J; GIMLETTE TM; HUTCHINSON JS; MCSWINEY RR; MILLS IH
    J Clin Endocrinol Metab; 1963 Aug; 23():737-46. PubMed ID: 14059550
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differential diagnosis and medical treatment in Cushing's disease].
    Beckers A; Valdes-Socin H; Betea D; Stevenaert A
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):163-72. PubMed ID: 12058123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [COMPARISON OF THE CHARACTERISTICS OF ADRENOCORTICAL HYPERFUNCTION IN SIMPLE OBESITY AND IN CUSHING'S SYNDROME].
    SCHTEINGART DE; GREGERMAN RY; CONN JW
    Dia Med; 1964 Apr; 36():306-7. PubMed ID: 14145602
    [No Abstract]   [Full Text] [Related]  

  • 19. APPRAISAL OF ADRENOCORTICAL HYPERFUNCTION: PATIENTS WITH CUSHING'S SYNDROME OR "NON-ENDOCRINE" TUMORS.
    BROOKS RV; DUPRE J; GOGATE AN; MILLS IH; PRUNTY FT
    J Clin Endocrinol Metab; 1963 Aug; 23():725-36. PubMed ID: 14059549
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of Cushing's syndrome caused by adrenal cortex hyperplasia, using 6-dehydro-16-methylenehydrocortisone].
    Rausch-Stroomann JG; Petry R; Trenkner G
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2324-31. PubMed ID: 5696572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.